Author: George Underwood

Bedrock, DDB Remedy and Insypher lead the agency field, Gilead tops the pharma chart

Janssen ranks first in new survey of pharma’s reputation among mental health patient groups

Oversubscribed financing includes investment from Pfizer and Novartis

Strong performances for Mavenclad and Bavencio

Chairman says consumer and Rx platforms are “navigating divergent industry dynamics”